| Q42145269 | Bosentan effects in hypoxic pulmonary vasoconstriction: Preliminary study in subjects with or without high altitude pulmonary edema-history |
| Q24613597 | Cardiopulmonary function in two human disorders of the hypoxia-inducible factor (HIF) pathway: von Hippel-Lindau disease and HIF-2alpha gain-of-function mutation |
| Q38112028 | Determinants of pulmonary blood flow distribution |
| Q36960179 | Effect of acetazolamide and gingko biloba on the human pulmonary vascular response to an acute altitude ascent. |
| Q84590050 | Effects of epoprostenol and sildenafil on right ventricular function in hypoxic volunteers: a tissue Doppler imaging study |
| Q34774869 | Elevated pulmonary artery pressure among Amhara highlanders in Ethiopia |
| Q38555899 | Elevated pulmonary artery pressure and brain natriuretic peptide in high altitude pulmonary edema susceptible non-mountaineers |
| Q35148156 | Environmental insults: smoke inhalation, submersion, diving, and high altitude |
| Q37632676 | Exercise-induced interstitial pulmonary edema at sea-level in young and old healthy humans |
| Q37070087 | Exercise-induced pulmonary hypertension: physiological basis and methodological concerns |
| Q45908457 | Heart-lung interaction in a model of COPD: importance of lung volume and direct ventricular interaction. |
| Q57101946 | High-altitude medicine |
| Q38110502 | High-altitude pulmonary edema |
| Q35868163 | Human pulmonary vascular responses to hypoxia and hypercapnia. |
| Q57736221 | Intérêt de l’épreuve fonctionnelle d’exercice dans la détection de l’hypertension pulmonaire d’exercice |
| Q28080704 | Iron, oxygen, and the pulmonary circulation |
| Q35550645 | Left ventricular function during acute high-altitude exposure in a large group of healthy young Chinese men. |
| Q57102069 | Lung disease at high altitude |
| Q82597139 | Moderate Altitude Increases Right Ventricular Pressure and Oxygen Desaturation in Adolescents with Surgically Closed Septal Defect |
| Q28218986 | Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiology |
| Q84393080 | Non-invasive measurement of the response of right ventricular pressure to exercise, and its relation to aerobic capacity |
| Q93028342 | Opioid Toxicity |
| Q26849250 | Physiology in Medicine: A physiologic approach to prevention and treatment of acute high-altitude illnesses |
| Q57824372 | Primary pulmonary hypertension may be a heterogeneous disease with a second locus on chromosome 2q31 |
| Q30479456 | Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study |
| Q36344657 | Pulmonary circulation at exercise |
| Q64991397 | Pulmonary hypertension subjects exhibit right ventricular transient exertional dilation during supine exercise stress echocardiography. |
| Q42229035 | Raised HIF1α during normoxia in high altitude pulmonary edema susceptible non-mountaineers |
| Q38937063 | Rest and exercise echocardiography for early detection of pulmonary hypertension |
| Q46971521 | Right ventricular function with hypoxic exercise: effects of sildenafil |
| Q47766597 | Separating the direct effect of hypoxia from the indirect effect of changes in cardiac output on the maximum pressure difference across the tricuspid valve in healthy humans |
| Q31934846 | Stress echocardiography in the diagnosis of coronary artery disease |
| Q45985128 | Susceptibility to high-altitude pulmonary edema is associated with a more uniform distribution of regional specific ventilation. |
| Q88093778 | Systolic pulmonary artery pressure assessed during routine exercise Doppler echocardiography: insights of a real-world setting in patients with elevated pulmonary pressures |
| Q57105896 | The effect of 18 h of simulated high altitude on left ventricular function |
| Q34490610 | The use of pulmonary function testing in piloting, air travel, mountain climbing, and diving |
| Q39316798 | Thin Air Resulting in High Pressure: Mountain Sickness and Hypoxia-Induced Pulmonary Hypertension. |
| Q34917895 | Variations in alveolar partial pressure for carbon dioxide and oxygen have additive not synergistic acute effects on human pulmonary vasoconstriction |